2025 HCPCS Code M0250
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
TAGS: systemic years patients invasive corticosteroids extracorporeal receiving supplemental pediatric hospitalized oxygenation second administration require membrane infusion intravenous adults mechanical| Short Description | Adm tocilizu covid-19 2nd |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | June 24, 2021 |
| HCPCS Action Effective Date | June 24, 2021 |
| HCPCS Pricing Indicator Code | 54 - Vaccinations |
| HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- M1380 - 2 rx in perf pd any com meds
- M1381 - Pt sec strk wthin 5 days
- M1382 - Enc dur perf pd pos 11
- M1383 - Acute pvd
- M1384 - Pt died dur perf pd
- M1385 - Pt rsn not seen 2nd pam
- M1386 - Exc sx melmn or mlnm is
- M1387 - Pt died dur perf pd
- M1388 - Pt doc exm rec melmn
- M1390 - Pt no doc exm for rec
- M1391 - All pt dx w/ rec mlnm
- M1392 - Pt rsn no exm or lst to fu
- M1393 - Pr no dx rec mlnm
- M1394 - Stg i-iii br ca
- M1395 - Init chemo w/def dur ec grp
- M1396 - Pt ther clin trial
- M1397 - Pt w/ recur/prog
- M1398 - Bslne and fu promis doc
- M1399 - Pt lve prac
- M1400 - Pt died dur perf pd
